Biosimilars Boost Offsets Generics Slide For Sandoz
Sales Remain Steady In 2020 Despite Turbulence Of COVID-19
Despite the turbulence of 2020 and the pressures of the coronavirus pandemic, Sandoz has reported steady sales for the year, as biopharmaceuticals sales up by a fifth offset a slide in turnover from retail generics.
